LIANHE TECHNOLOGY(SZ:002250) Xin Lang Cai Jing·2025-06-11 09:48Core Viewpoint - Lianhua Technology (联化科技) experienced a significant stock price drop after a period of rapid increase, with a trading halt on June 11, 2023, closing at 13.32 yuan, following a peak increase of over 124% in the previous weeks [2][4]. Group 1: Stock Performance - On June 11, Lianhua Technology's stock hit the daily limit down, with a trading volume of 22.09 million hands and a transaction value of 3.08 billion yuan, including over 650,000 hands traded at the limit down price [2]. - From May 28 to June 10, the stock recorded six limit up days out of nine trading days, indicating high volatility and investor interest [2]. Group 2: Company Operations - Lianhua Technology confirmed that there were no undisclosed significant matters affecting stock trading, and its production and operational conditions remain normal [2][4]. - The company operates under a CDMO model for producing advanced intermediates for chlorantraniliprole, maintaining a long-term partnership with its client, but has not received any notifications regarding increased product demand [4]. Group 3: Financial Performance - For the fiscal years 2022 to 2024, Lianhua Technology reported revenues of 7.865 billion yuan, 6.442 billion yuan, and 5.677 billion yuan, with net profits of 697 million yuan, -465 million yuan, and 103 million yuan respectively [4]. - In Q1 2025, the company achieved a revenue of 1.51 billion yuan, a year-on-year increase of 3.02%, and a net profit of 49.72 million yuan, reflecting a substantial year-on-year growth of 1747.04% [6]. Group 4: Business Segments - The improvement in Q1 2025 was attributed to the recovery of gross margins in the plant protection segment and steady development in the pharmaceutical segment, along with gains from foreign exchange [7]. - Despite the positive performance, the company faces challenges in the competitive new energy market, which has put pressure on its financial results due to depreciation of fixed assets [7].